Posters

PXL770, a direct AMPK activator, shows favorable cardiac safety profile

Sophie Hallakou-Bozec et al. — October 2018, Toronto, Canada

Imeglimin Improves Vascular Dysfunction in Type 2 Diabetes Animal Models EASD

Fouqueray P et al. — September 2016, Munich, Germany

Imeglimin Improves Insulin Sensitivity in an Adult STZ Rat Model ADA

Sophie Hallakou-Bozec et al. — June 2016, New Orleans, USA

PXL770 Demonstrates Therapeutic Potential as a New Direct AMP Kinase Activator WCIRDC

Sophie Hallakou-Bozec et al. — November 2015, Los Angeles, USA